Early Treatment Response Assessment Using

Adult Aged Brain Neoplasms Glioma Humans Middle Aged Temozolomide Young Adult
amino acid PET metabolic tumor volume pseudoprogression treatment monitoring treatment-related changes

Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
01 07 2021
Historique:
received: 28 07 2020
revised: 08 10 2020
pubmed: 8 11 2020
medline: 6 1 2022
entrez: 7 11 2020
Statut: ppublish

Résumé

The goal of this study was to compare the value of contrast-enhanced MRI and O-(2-[

Identifiants

DOI: 10.2967/jnumed.120.254243 PMID: 33158907
pubmed: 33158907
pii: jnumed.120.254243
doi: 10.2967/jnumed.120.254243
doi:

Substances chimiques

Temozolomide YF1K15M17Y

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

918-925

Informations de copyright

© 2021 by the Society of Nuclear Medicine and Molecular Imaging.

Auteurs

Garry Ceccon (G)

Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Germany.

Philipp Lohmann (P)

Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany.

Jan-Michael Werner (JM)

Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Germany.

Caroline Tscherpel (C)

Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Germany.
Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany.

Veronika Dunkl (V)

Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Germany.

Gabriele Stoffels (G)

Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany.

Jurij Rosen (J)

Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Germany.

Marion Rapp (M)

Department of Neurosurgery, University Hospital Duesseldorf, Duesseldorf, Germany.

Michael Sabel (M)

Department of Neurosurgery, University Hospital Duesseldorf, Duesseldorf, Germany.

Ulrich Herrlinger (U)

Division of Clinical Neurooncology, Department of Neurology, University Hospital Bonn, Bonn, Germany.
Center of Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Duesseldorf, Aachen and Cologne, Germany.

Niklas Schäfer (N)

Division of Clinical Neurooncology, Department of Neurology, University Hospital Bonn, Bonn, Germany.
Center of Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Duesseldorf, Aachen and Cologne, Germany.

Nadim J Shah (NJ)

Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany.
Department of Neurology, University Hospital Aachen, Aachen, Germany; and.

Gereon R Fink (GR)

Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Germany.
Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany.

Karl-Josef Langen (KJ)

Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany.
Center of Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Duesseldorf, Aachen and Cologne, Germany.
Department of Nuclear Medicine, University Hospital Aachen, Aachen, Germany.

Norbert Galldiks (N)

Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Germany; n.galldiks@fz-juelich.de.
Institute of Neuroscience and Medicine (INM-3, -4), Research Center Juelich, Juelich, Germany.
Center of Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Duesseldorf, Aachen and Cologne, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Early Treatment Response Assessment Using
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Early Treatment Response Assessment Using
questionsmedicales.fr › Maladies du système nerveux › Tumeurs du système nerveux › Tumeurs du système nerveux central › Tumeurs du cerveau › Early Treatment Response Assessment Using
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Tumeurs du tissu nerveux › Tumeurs neuroectodermiques › Tumeurs neuroépitheliales › Gliome › Early Treatment Response Assessment Using
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Early Treatment Response Assessment Using
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Early Treatment Response Assessment Using
questionsmedicales.fr › Composés hétérocycliques › Composés hétéromonocycliques › Azoles › Imidazoles › Dacarbazine › Témozolomide › Early Treatment Response Assessment Using
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Jeune adulte › Early Treatment Response Assessment Using